Workflow
AI platform for retina image analysis
icon
Search documents
DIAGNOS Welcomes Veteran Optometrist Dr. Barry A. Ginsberg to its Scientific Advisory Board for the United States
Globenewswire· 2025-06-25 13:00
BROSSARD, Quebec, June 25, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. ("DIAGNOS" or the "Corporation") (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health issues using advanced technology based on Artificial Intelligence (AI), is thrilled to announce that Dr. Barry A. Ginsberg, O.D. has joined the Corporation's Advisory Board. Mr. Weiner will team up with Dr. Tomas J. Philipson, former vice chairman and acting chairman of the White House Council of Economic Advisers and M ...
DIAGNOS Welcomes Former White House Economic Adviser Dr. Tomas J. Philipson to its Advisory Board for the US Market
Globenewswire· 2025-06-04 10:30
Core Insights - Diagnos Inc. has appointed Dr. Tomas J. Philipson to its Advisory Board, enhancing its expertise in healthcare policy and economic strategy [1][7] - The company focuses on early detection of critical eye-related health issues using AI technology, aiming to improve diagnostic accuracy and patient outcomes [8] Company Overview - Diagnos Inc. is a publicly traded Canadian corporation dedicated to leveraging AI for early detection of eye health problems [8] - The company has developed an AI platform that analyzes retina images, which are collected from thousands of optometrists globally [7] Market Potential - In 2020, the US conducted approximately 111 million routine eye exams and 60 million medical eye exams, indicating a significant market opportunity for Diagnos [7] - The recent establishment of a US office in South Florida aims to support the company's growth and client engagement in this expanding market [7] Advisory Board Expertise - Dr. Philipson is recognized for his extensive experience in US economic policy, particularly in healthcare, and has served in various high-level government roles [2][4] - His background includes being a managing partner at MEDA Ventures and co-founding Precision Health Economics LLC, showcasing his entrepreneurial and investment acumen [3][4] Academic and Professional Recognition - Dr. Philipson has received numerous awards in health economics, including the Arrow Award and the Garfield Award for Economic Research, highlighting his contributions to the field [5] - He holds advanced degrees in mathematics and economics from prestigious institutions, further solidifying his expertise [6]